Earnings call Pernod Ricard reported FY25 organic sales down 3% YoY, impacted by softness in China (-21%) and the U.S. (-6%), but achieved 64 bps organic margin expansion and 18% growth in free cash ...
Read the latest healthcare, biotech, and pharmaceutical stock news and analysis. Uncover the latest research and company analysis to empower your investments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results